Page 29 - NNS 2014 Program & Abstract Book
Basic HTML Version
NOTES
Disclosure of Con!icts
Neurotrauma 2014
Disclosure Information
Disclosures
27
Beattie, Michael
Sano!-Aventis: Grants/Research Support
Recipient
Blight, Andrew
Acorda Therapeutics, Inc.: Employee
Bond, Lisa
BioAxone BioSciences, Inc.: Employee
Ghajar, Jam
SyncThink: Board Member
Hayes, Ronald
Banyan Biomarkers, Inc.: Shareholder
Hook, Greg
American Life Science Pharmaceuticals:
Employee and Shareholder
Huang, Zhihong
Acorda Therapeutics, Inc: Employee and
Shareholder
Jones, Stephen
CerebroScope: Board Member and Holder
of Intellectual Property Rights
Kwon, Brian
Acorda Therapeutics: Advisor or Review
Panel member
LeRoux, Peter
Integra: Consultant
Codman: Consultant
Neurologica: Consultant
Synthes: Consultant
Edge Therapeutics: Advisor or Review
Panel member
Lum, Pek
Ayasdi: Employee
Naik, Bhiken
Advanced Circulatory Systems Inc:
Honorarium Recipient
Nelson, Neta
Besins Healthcare/ BHR Pharma, LLC:
Employee
Poellabauer, Christian
Contect, Inc.: Shareholder
Samadani, Uzma
Oculogica Inc.: Shareholder
Sche", Stephen
Precision Systems & Instrumentation:
Consultant
Schneider, Eric
Bergeim, LLC.: Board Member
Self: Holder of Intellectual Property Rights
Steeves, John
Asubio: Consultant
Alseres: Consultant
Neuralstem: Consultant
Novartis: Consultant
StemCells: Consultant
Switzer III, Robert
NeuroScience Associates: Independent
Contractor
Wang, Kevin
Banyan Biomarkers, Inc.: Shareholder
Wirth, Edward
Asterias Biotherapeutics, Inc.: Employee
The following speakers / presenting authors report the following relevant relationships:
Adhering to the ACCME Standards (see
), all relationships reported have been resolved according to VCU’s Policy on Con"ict of Interest.
All presenting faculty a#rm that they will employ the best available evidence from all sources to support any clinical recommendations made in their
presentations. If learners detect any commercial bias in any presentation, they should document their observations on the Activity Evaluation Form.
